Quick Takeaways
- Kynam Capital Management, LP filed SCHEDULE 13G for Viridian Therapeutics, Inc. Common Stock, $0.01 par value (VRDN).
- Disclosed ownership: 5.8%.
- Date of event: 31 Mar 2025.
Kynam Capital Management, LP - 31 Mar 2025 SCHEDULE 13G Report for Viridian Therapeutics, Inc. Common Stock, $0.01 par value (VRDN)
- Filing Manager
- Kynam Capital Management, LP
- Reporting Manager
- Kynam Capital Management, LP
- Symbol
- VRDN
- Disclosed Ownership
- 0 shares
- Ownership
- 5.8%
- Form type
- SCHEDULE 13G
- Filing time
- 15 May 2025, 11:44:42 UTC
- Date of event
- 31 Mar 2025
- Next filing
- 17 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Kynam Capital Management, LP disclosed 5.8% ownership in Viridian Therapeutics, Inc. Common Stock, $0.01 par value (VRDN) on 31 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 15 May 2025, 11:44.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Kynam Capital Management, LP | 5.8% | 0 | 0 | 4,700,000 | Yue Tang | Managing Member | |
| Kynam Capital Management GP, LLC | 5.8% | 0 | 0 | 4,700,000 | Yue Tang | Managing Member | |
| Yue Tang | 5.8% | 0 | 0 | 4,700,000 | Yue Tang | Self |